Explore Oncolytics Biotech Inc.'s February 2025 SEC Form 6-K report, detailing compliance, key signatures, and regulatory filings. Stay informed on biotech updates!
High Tide Inc. announces Q4 and FY 2024 financial results in this crucial 6-K report. Key insights for investors on company performance and transparency.
Explore XORTX Therapeutics Inc.'s Form 6-K filing, dated January 6, 2025, detailing compliance, CEO signature, and press release highlights.
Explore High Tide Inc.'s Form 6-K report for December 2024, highlighting achievements and regulatory compliance. Insights on executive accountability and company performance.